COVID-19 CORONAVIRUS INFECTION IN PATIENTS WITH CARDIOVASCULAR DISEASES
Keywords:
COVID-19, coronavirus infection, cardiovascular diseases, arterial hypertension, comorbidity, chronic heart failure, cardiac arrhythmiaAbstract
At the present stage, COVID-19 remains an urgent medical and social health problem worldwide. During the pandemic period, over 765 million cases of COVID-19 were registered, with 6.9 million cases resulting in death. Mortality from infection varies widely depending on the region of residence, age, concomitant conditions, availability of medical care, the level of diagnostic coverage and the system's readiness to provide care to a large number of patients with severe course and ranges from 1 to 5%.
References
1. Harrison SL, Fazio-Eynullayeva A, Lane DA, Underhill P, Lip GYH. Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic health record analysis. PLoS Med. 2020;17(9):e1003321.
2. Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol. 2020;17(9):543-558.
3. Inciardi RM, Lupi L, Zaccone G, et al. Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):819-824.
4. Bavishi C, Bonow RO, Trivedi V, Abbott JD, Sripal Bangalore S. Acute myocardial injury in patients hospitalized with COVID-19: A review. Progress in Cardiovascular Diseases. 2021;64(4):682-689.
5. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020;323(20):2052-2059.
